In fact, human PRNP transcription is decreased during normal aging [32] and in some neuropathological contexts where GSK3β activity is upregulated, such as advanced Alzheimer’s disease (AD) [33, 34]. This evidence concerns the gene GSK3B and Alzheimer disease.